O
GTS

OrbiMed’s Triple-S Management Corporation GTS Stock Holding History

OrbiMed’s Portfolio GTS Stock Details GTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-305,662
Closed -$11.4M – 162
2018
Q2 		$11.4M Sell
305,662
-289,265
-49% -$9.14M 0.14% 107
2018
Q1 		$14.8M Buy
+594,927
New +$14.2M 0.18% 90

Other funds holding GTS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

OrbiMed's GTS Position: Q3 2018 in Review

OrbiMed sold out of Triple-S Management Corporation (GTS) in Q3 2018, closing a stake of 305,662 shares — an estimated $11.4M sold.

OrbiMed first reported a position in GTS in Q1 2018 and held it in 2 quarters. The position peaked at $14.8M in Q1 2018. 115 funds tracked by Wall St. Rank hold GTS as of Q3 2018.

  • OrbiMed reported no remaining Triple-S Management Corporation position as of Q3 2018 after selling out during the quarter.
  • OrbiMed sold 305,662 Triple-S Management Corporation shares in Q3 2018, an estimated $11.4M.
  • OrbiMed first reported a position in Triple-S Management Corporation in Q1 2018 and held it in 2 quarters.
  • OrbiMed's Triple-S Management Corporation position peaked at $14.8M in Q1 2018.
  • 115 funds tracked by Wall St. Rank held Triple-S Management Corporation as of Q3 2018.

Based on OrbiMed's 13F filing for Q3 2018, filed 14 Nov 2018.